Molecular Diagnostics in Europe Industry Market Status, Opportunities and Market Forecasts by 2023
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Europe</strong> <strong>Industry</strong> <strong>Market</strong> <strong>Status</strong>,<br />
<strong>Opportunities</strong> <strong>and</strong> <strong>Market</strong> <strong>Forecasts</strong> <strong>by</strong> <strong>2023</strong><br />
Report Description<br />
This report on the molecular diagnostics market studies the<br />
current <strong>and</strong> future prospects of the market <strong>in</strong> <strong>Europe</strong>.<br />
Grow<strong>in</strong>g <strong>in</strong>cidences of chronic <strong>in</strong>fectious diseases such as
tuberculosis, HIV/AIDS, diarrhea, pneumonia, <strong>in</strong> addition to<br />
<strong>in</strong>creas<strong>in</strong>g geriatric population, <strong>and</strong> ris<strong>in</strong>g number of<br />
biotechnology companies is expected to accentuate the growth<br />
of molecular diagnostics market <strong>in</strong> <strong>Europe</strong>. The <strong>Europe</strong><br />
molecular diagnostics market report comprises an elaborate<br />
executive summary, which <strong>in</strong>cludes a market snapshot that<br />
provides <strong>in</strong>formation about various segments <strong>and</strong> subsegments<br />
of the market. It also provides <strong>in</strong>formation <strong>and</strong> data<br />
analysis of the <strong>Europe</strong> molecular diagnostics market with<br />
respect to market segments based on technology, application<br />
<strong>and</strong> their geographic analysis. <br />
<br />
Read Complete Report @ http://www.mrrse.com/europemolecular-diagnostics-market
Based on technology, the molecular diagnostics market <strong>in</strong><br />
<strong>Europe</strong> has been segmented <strong>in</strong>to seven major categories:<br />
polymerase cha<strong>in</strong> reaction, hybridization (ISH AND FISH),<br />
mass spectrometry, transcription mediated amplification<br />
(TMA), next generation sequenc<strong>in</strong>g, biochips <strong>and</strong><br />
microfluidics, others which <strong>in</strong>cludes nanotechnology <strong>and</strong><br />
proteomics. Likewise, on the basis of application, the <strong>Europe</strong><br />
molecular diagnostics market has been segmented <strong>in</strong>to<br />
oncology, <strong>in</strong>fectious disease test<strong>in</strong>g, genomics, blood<br />
screen<strong>in</strong>g, women's health, microbiology, <strong>and</strong> prenatal <strong>and</strong><br />
newborn screen<strong>in</strong>g. Infectious disease test<strong>in</strong>g has been<br />
segmented <strong>in</strong>to two major categories, namely, virology <strong>and</strong><br />
bacteriology. Virology segment <strong>in</strong>cludes human
immunodeficiency virus (HIV) test<strong>in</strong>g, human para<strong>in</strong>fluenza<br />
virus (1, 2, 3, 4) test<strong>in</strong>g, human respiratory syncytial virus<br />
(A, B) test<strong>in</strong>g, human papillomavirus (HPV) test<strong>in</strong>g, human<br />
rh<strong>in</strong>ovirus A/B test<strong>in</strong>g, hepatitis C virus (HCV) test<strong>in</strong>g, <strong>and</strong><br />
others which <strong>in</strong>cludes human adenovirus (A/B/C/D/E),<br />
<strong>in</strong>fluenza (A, B), etc. Bacteriology <strong>in</strong>cludes hospital acquired<br />
<strong>in</strong>fection (HAI) test<strong>in</strong>g, chlamydophila pneumonia test<strong>in</strong>g,<br />
chlamydia trachomatis <strong>and</strong> Neisseria gonorrhoeae (CT/NG)<br />
test<strong>in</strong>g, staphylococcus aureus test<strong>in</strong>g (MRSA), <strong>and</strong> others<br />
which <strong>in</strong>cludes haemophilus <strong>in</strong>fluenza, mycoplasma<br />
pneumonia, etc. The market segments have been extensively<br />
analyzed based on usefulness, adoption, efficacy, revenue,<br />
<strong>and</strong> geographical coverage. The market size <strong>and</strong> forecast <strong>in</strong><br />
terms of US$ Mn for each segment has been provided for the
period from 2013 to <strong>2023</strong>. The molecular diagnostics market<br />
report also provides the compound annual growth rate (CAGR<br />
%) for each market segment for the forecast period from 2015<br />
to <strong>2023</strong>, consider<strong>in</strong>g 2014 as the base year. A brief patient<br />
pool analysis <strong>by</strong> <strong>in</strong>fectious disease, cancer <strong>and</strong> cardiovascular<br />
disease have also been discussed <strong>in</strong> the <strong>Europe</strong> molecular<br />
diagnostics report. <br />
<br />
Geographically, the molecular diagnostics market <strong>in</strong> <strong>Europe</strong><br />
has been categorized <strong>in</strong>to five major regions: Northern<br />
<strong>Europe</strong>, Eastern <strong>Europe</strong>, Western <strong>Europe</strong>, Southern <strong>Europe</strong>,<br />
<strong>and</strong> Rest of <strong>Europe</strong>. The market size <strong>and</strong> forecast for each of<br />
these regions has been provided for the period from 2013 to<br />
<strong>2023</strong>, along with their respective CAGRs for the forecast
period from 2015 to <strong>2023</strong>, consider<strong>in</strong>g 2014 as the base year.<br />
The research study also covers the competitive scenario <strong>in</strong><br />
these regions. A detailed qualitative analysis of factors<br />
responsible for driv<strong>in</strong>g <strong>and</strong> restra<strong>in</strong><strong>in</strong>g the growth of the<br />
market <strong>and</strong> future opportunities has been provided <strong>in</strong> the<br />
market overview section. This section of the report also<br />
provides market attractiveness analysis, Porter’s Five Forces<br />
analysis, ADL matrix, growth share matrix, <strong>and</strong> market share<br />
analysis <strong>by</strong> key players, thus present<strong>in</strong>g a thorough analysis<br />
of the overall competitive scenario <strong>in</strong> the <strong>Europe</strong> molecular<br />
diagnostics market. <br />
<br />
Get a Free Sample Copy of the Report @<br />
http://www.mrrse.com/sample/1624
Current <strong>and</strong> future trends has also been provided for new<br />
entrants as well as exist<strong>in</strong>g market players to assist them <strong>in</strong><br />
tak<strong>in</strong>g strategic <strong>in</strong>itiatives to establish a strong presence <strong>in</strong><br />
the market. The report also profiles major players <strong>in</strong> the<br />
<strong>Europe</strong> molecular diagnostics market based on various<br />
attributes such as company overview, f<strong>in</strong>ancial overview,<br />
product portfolio, bus<strong>in</strong>ess strategies, <strong>and</strong> recent<br />
developments. Major players profiled <strong>in</strong> this report <strong>in</strong>clude F.<br />
Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V.,<br />
Hologic, Inc., Cepheid, Inc., Siemens AG, Alere. Inc.,<br />
BioMerieux, Bio-Rad Laboratories, Perk<strong>in</strong>Elmer, Inc., Thermo<br />
Fisher Scientific, Inc., <strong>and</strong> others.
The <strong>Europe</strong> molecular diagnostics market is segmented as<br />
given below:<br />
<br />
<strong>Europe</strong> <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, <strong>by</strong> Technology<br />
<br />
Polymerase Cha<strong>in</strong> Reaction<br />
Hybridization (ISH <strong>and</strong> FISH)<br />
Mass Spectrometry<br />
Transcription Mediated Amplification (TMA)<br />
Next Generation Sequenc<strong>in</strong>g<br />
Biochips <strong>and</strong> Microfluidics<br />
Others (Nanotechnology <strong>and</strong> Proteomic)<br />
<strong>Europe</strong> <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>, <strong>by</strong> Application
Oncology<br />
Infectious Disease Test<strong>in</strong>g<br />
Genomics<br />
Blood Screen<strong>in</strong>g<br />
Women's Health<br />
Microbiology<br />
Prenatal <strong>and</strong> Newborn Screen<strong>in</strong>g<br />
<strong>Europe</strong> <strong>Molecular</strong> <strong>Diagnostics</strong> Drugs <strong>Market</strong>, <strong>by</strong> Major Region<br />
<strong>and</strong> Countries<br />
<br />
Northern <strong>Europe</strong><br />
Irel<strong>and</strong><br />
Norway<br />
Sweden
United K<strong>in</strong>gdom<br />
Rest of Northern <strong>Europe</strong> (Denmark, F<strong>in</strong>l<strong>and</strong>)<br />
Eastern <strong>Europe</strong><br />
Ukra<strong>in</strong>e<br />
Pol<strong>and</strong><br />
Czech Republic<br />
Russia<br />
Rest of Eastern <strong>Europe</strong> (Hungary, Romania)<br />
Western <strong>Europe</strong><br />
France<br />
Germany<br />
Austria<br />
Rest of Western <strong>Europe</strong> (Netherl<strong>and</strong>s, Belgium)<br />
Southern <strong>Europe</strong>
Italy<br />
Spa<strong>in</strong><br />
Portugal<br />
Rest of Southern <strong>Europe</strong> (Greece, Switzerl<strong>and</strong>)<br />
Rest of <strong>Europe</strong><br />
About MRRSE<br />
MRRSE st<strong>and</strong>s for <strong>Market</strong> Research Reports Search Eng<strong>in</strong>e,<br />
the largest onl<strong>in</strong>e catalog of latest market research reports<br />
based on <strong>in</strong>dustries, companies, <strong>and</strong> countries. MRRSE<br />
sources thous<strong>and</strong>s of <strong>in</strong>dustry reports, market statistics, <strong>and</strong><br />
company profiles from trusted entities <strong>and</strong> makes them<br />
available at a click. Besides well-known private publishers,
the reports featured on MRRSE typically come from national<br />
statistics agencies, <strong>in</strong>vestment agencies, lead<strong>in</strong>g media houses,<br />
trade unions, governments, <strong>and</strong> embassies.<br />
Contact US:<br />
Corporate Office<br />
State Tower<br />
90 State Street, Suite 700<br />
Albany, NY 12207<br />
United States
Tel: +1-518-730-0559<br />
Email: sales@mrrse.com
Change language